Thursday, March 19, 2020

Helicobacter Pylori Non-Invasive Testing Market to Witness Growth Acceleration During 2019-2030 - Meridian Bioscience, DiaSorin, Exalenz Bioscience

Helicobacter pylori (H. pylori) is a bacteria that thrives in the digestive tract and can infest the stomach lining resulting in sores, also called ulcers, over a period of time. This bacteria usually lining infects the lining of the stomach or the upper part of the small intestine. This infection can lead to peptic ulcers and gastritis. In certain cases, this prolonged infection can lead to stomach cancer. In 1Hospitals, Clinics, Diagnostic Laboratories4, the WHO's, International Agency for Research on Cancer classified H. pylori as a Class 1 carcinogen. As more parts of the world get access to clean water and sanitation, the prevalence of H. pylori will decrease. With good health habits and sanitation is possible to safeguard yourself against this infection.

Market Industry Reports (MIR) has published a new report titled "Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the helicobacter pylori (H. pylori) non-invasive testing market was estimated to be over US$ 500 Mn in 2018. It is anticipated to grow at a CAGR of 3.8% from 2019 to 2030.

Major Key Players of the Helicobacter Pylori Non-Invasive Testing Market are:
Meridian Bioscience, DiaSorin, Exalenz Bioscience, Thermo Fisher Scientific, Alere, Certest Biotec S.L, Sekisui Diagnostics, Biomerica, Inc, CorisBioconcept SPRL, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. among others.

Read More @ http://www.sbwire.com/press-releases/helicobacter-pylori-non-invasive-testing-market-to-witness-growth-acceleration-during-2019-2030-meridian-bioscience-diasorin-exalenz-bioscience-1282195.htm 


No comments:

Post a Comment